Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.37
+0.03 (0.21%)
At close: Mar 9, 2026, 4:00 PM EDT
14.38
+0.01 (0.07%)
After-hours: Mar 9, 2026, 6:45 PM EDT
Amicus Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -27.11 | -56.11 | -151.58 | -236.57 | -250.46 | |
| Depreciation & Amortization | 7.46 | 8.55 | 7.87 | 5.34 | 6.21 | |
| Other Amortization | 2.57 | 2.26 | 2.62 | 2.63 | 2.49 | |
| Asset Writedown & Restructuring Costs | -1.14 | 9.21 | 2.73 | 18.18 | - | |
| Stock-Based Compensation | 87.41 | 84.91 | 86.08 | 76.51 | 57.84 | |
| Other Operating Activities | 3.59 | 16.23 | 31.19 | 7.21 | 10.37 | |
| Change in Accounts Receivable | -5.86 | -19.48 | -20.11 | -17.33 | -8.19 | |
| Change in Inventory | -111.48 | -73.65 | -44.61 | -5.34 | -7.79 | |
| Change in Accounts Payable | 82.78 | -16.52 | 49.2 | -6.38 | 7.43 | |
| Change in Other Net Operating Assets | -5.07 | 10.71 | -32.46 | -10.83 | -20.39 | |
| Operating Cash Flow | 33.15 | -33.89 | -69.09 | -166.58 | -202.49 | |
| Capital Expenditures | -3.3 | -3.55 | -7.44 | -3.77 | -3.88 | |
| Sale of Property, Plant & Equipment | - | - | - | 3.41 | - | |
| Investment in Securities | -43.14 | 2.99 | 105.5 | 92.67 | 82.65 | |
| Investing Cash Flow | -46.43 | -0.56 | 98.06 | 92.32 | 78.76 | |
| Long-Term Debt Issued | - | - | 387.36 | - | - | |
| Long-Term Debt Repaid | -0.27 | -0.1 | -408.32 | -0.28 | -0.48 | |
| Net Debt Issued (Repaid) | -0.27 | -0.1 | -20.96 | -0.28 | -0.48 | |
| Issuance of Common Stock | 19.21 | 27.24 | 103.21 | 4.31 | 229.21 | |
| Repurchase of Common Stock | -18.32 | -22.03 | -17.92 | -11.49 | -15.01 | |
| Other Financing Activities | - | - | -2.65 | - | -1.65 | |
| Financing Cash Flow | 0.61 | 5.12 | 61.68 | -7.46 | 212.07 | |
| Foreign Exchange Rate Adjustments | 13.28 | -4.03 | 6.31 | -14.62 | -5.05 | |
| Net Cash Flow | 0.6 | -33.36 | 96.96 | -96.34 | 83.29 | |
| Free Cash Flow | 29.85 | -37.44 | -76.53 | -170.34 | -206.38 | |
| Free Cash Flow Margin | 4.71% | -7.09% | -19.16% | -51.74% | -67.55% | |
| Free Cash Flow Per Share | 0.10 | -0.12 | -0.26 | -0.59 | -0.76 | |
| Cash Interest Paid | 43.61 | 58.96 | 36.09 | 34.36 | 30.47 | |
| Cash Income Tax Paid | 14.89 | 8.21 | 8.53 | 1.61 | 20.03 | |
| Levered Free Cash Flow | 47.84 | 5.41 | -25.89 | -94.23 | -84.97 | |
| Unlevered Free Cash Flow | 74.12 | 34.14 | 2.84 | -73.66 | -67.16 | |
| Change in Working Capital | -39.63 | -98.94 | -47.99 | -39.88 | -28.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.